Navigation Links
Component in soy products causes reproductive problems in laboratory mice

Genistein, a major component of soy, was found to disrupt the development of the ovaries in newborn female mice that were given the product. This study adds to a growing body of literature demonstrating the potentially adverse consequences of genistein on the reproductive system.

"Although we are not entirely certain about how these animal studies on genistein translate to the human population, there is some reason to be cautious," said Dr. David A. Schwartz, Director of the National Institute of Environmental Health Sciences (NIEHS). "More clinical studies are needed to determine how exposure during critical windows of development can impact human health."

Genistein is the primary naturally occurring estrogen in plants (called phytoestrogens) and can mimic the effects of estrogen in the body. Genistein can be found in foods containing soy such as soy-based infant formulas as well as over-the-counter dietary supplements.

The results of this study conducted by researchers at the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health, in collaboration with an investigator at Syracuse University, are published in the January issue of Biology of Reproduction.

The NIEHS researchers previously showed that mice given genistein immediately after birth had irregular menstrual cycles, problems with ovulation, and problems with fertility as they reached adulthood. The new study looks at the direct effects of genistein on the ovaries during early development.

"We knew genistein was linked to reproductive problems later in life, but we wanted to find out when the damage occurs," said Retha R. Newbold, MS, a developmental endocrinologist at NIEHS and an author on the study. "The study showed that genistein caused alterations to the ovaries during early development, which is partly responsible for the reproductive problems found in adult mice."

Female mice were injected with three different doses of genistein during their first five days of life. The genistein given to the mice was comparable to what human infants might receive in a soy-based formula, which is approximately 6-9 mg/kg per day. The researchers examined the effects on days 2 through 6.

The researchers found effects at all levels. Mice treated with the high dose (Gen 50 mg/kg) were infertile and mice treated with lower doses were subfertile, meaning they had fewer pups in each litter, and fewer pregnancies. Mice receiving the highest level of genistein, 50 mg/kg per day, had a high percentage of egg cells that remain in clusters, unable to separate and therefore develop abnormally. The researchers explain that oocytes that remain in clusters are less likely to become fertilized based on previous research. The largest difference between the genistein treated and normal mice was found at six days of age where 57 percent of the egg cells in the non-treated ovaries were single or unclustered; and only 36 percent in the genistein treated group were single

We think genistein inhibits the oocytes or egg cells from separating apart," said Wendy Jefferson, Ph.D. of NIEHS and lead researcher on the paper. "Since there are many egg cells in the same follicle instead of just one, the resources from the surrounding cells are spread too thin and they can't get the support they need to become a mature functioning egg cell."

"You need at least one good healthy single oocyte that is ovulated and fertilized by a sperm to get a healthy baby. Genistein seems to have a way of making this task very difficult," said Newbold.

"I don't think we can dismiss the possibility that these phytoestrogens are having an effect on the human population," said Dr. Jefferson. "They may not show their effects or be detected until later in life, but chances are they are having an effect."


'"/>

Source:NIH/National Institute of Environmental Health Sciences


Related biology news :

1. Estrogen-like Component of Plastic Stimulates Growth of Certain Prostate Cancer Cells
2. Drug-resistant bacteria on poultry products differ by brand
3. Compound in dairy products targets diabetes
4. In presence of fragrant cleaning products, air purifiers that emit ozone can dirty the air
5. BRCA1 causes ovarian cancer through indirect, biochemical route
6. Researchers discover molecule that causes secondary stroke
7. NASA study finds snow melt causes large ocean plant blooms
8. Alarm pheromone causes aphids to sprout wings
9. One hit of crystal meth causes birth defects
10. University of Nevada, Reno research team discovers hormone that causes malaria mosquito to urinate
11. Gene discovery sheds light on causes of rare disease, cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
(Date:3/28/2017)... March 28, 2017 The report ... (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), ... - Global Forecast to 2022", published by MarketsandMarkets, the ... and is projected to reach USD 75.64 Billion by ... 2022. The base year considered for the study is ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Global ... to 2025" report to their offering. ... The Global Biometric Vehicle Access System Market ... the next decade to reach approximately $1,580 million by 2025. ... for all the given segments on global as well as regional ...
Breaking Biology News(10 mins):
(Date:4/19/2017)... India , April 19, 2017 A new report ... and Industry Forecast, 2014-2022 ," the global market was valued at $6,769 million ... CAGR of 9.6% from 2016 to 2022. ... Allied Market ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) ...
(Date:4/19/2017)... and WESTMINSTER, Colo. , ... ("Oxford"), an industry-leading specialty finance firm that provides ... companies, today announced the closing of a $20 ... ("Cerapedics") a privately-held orthobiologics company engaged in the ... for the treatment of orthopedic injuries. ...
(Date:4/19/2017)... Mass. , April 19, 2017   ... results from the multi-center Procalcitonin MOnitoring SEpsis (MOSES) ... print issue of Critical Care Medicine . ... Mortality in Severe Sepsis Patients: Results From the ... use of the B·R·A·H·M·S PCT (procalcitonin) assay to ...
(Date:4/18/2017)... ... April 18, 2017 , ... ... been awarded Channel Partners 2017 Next-Gen Solution Provider. , Channel Partners program recognizes ... customers with their vision, innovation, and advocacy of the channel during transition and ...
Breaking Biology Technology: